Shalby Limited

BSE: 540797 NSE: SHALBY
Shalby Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN L85110GJ2004PLC044667 Incorporated 30 August 2004 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - NSE: SHALBY · BSE: 540797 Public Limited Company healthcare
Data last updated
Market Cap
₹1,409 Cr
SHALBY · NSE
Share Price
₹130.74
+0.25% today
Revenue
₹1,141 Cr
FY 2025-26 · +5.0% YoY
EBITDA
₹145 Cr
Margin 12.7%
Net Profit
₹24.48 Cr
FY 2025-26 · +305.9% YoY
P/E (TTM)
37.5x
P/B 1.5x
ROE
2.2%
ROCE 6.1%
Debt / Equity
0.54
Interest cover 55.0x

About Shalby Limited

Data last updated:

Shalby Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 30 August 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L85110GJ2004PLC044667. Its GSTIN is 03AAICS5593B1ZG (Punjab). The company holds 4 GST registrations, all of them active. Its shares are listed on BSE: 540797 and NSE: SHALBY.

The company has an authorised share capital of ₹117.75 Cr and a paid-up capital of ₹108.01 Cr. It was formerly known as Shalby Hospital Public Limited and Shalby Hospitals Limited. It is led by directors including Vikram Indrajit Shah (Managing Director) and Umesh Krishnankutty Menon.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Opp: Karnawati Club Sarkhej Gandhinagar Highway Nr.Prahladnagar Gardern, Ahmedabad, Gujarat, India – 380015.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,141.43 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹24.48 Cr (net margin 2.1%) and EBITDA of ₹145.07 Cr (EBITDA margin 12.7%). The net worth stands at ₹1,005.24 Cr (up 1.3% YoY). Total assets are valued at ₹1,615.13 Cr (up 8.7% YoY).

The company has about 2,529 employees on its provident fund (EPFO) records. Its group structure includes 6 subsidiaries.

The company is associated with 3 brands: Shalby Academy, Shalby and Shalby Hospitals. As per MCA filings, the company has open charges of ₹582.62 Cr and satisfied charges of ₹473.03 Cr on record. Court records list 84 cases involving the company, including 53 filed by the company and 22 filed against it; 16 cases are pending. The company has 30 deals on record (13 secondary share transfers, 9 market trades, 7 funding rounds), with disclosed funding of ₹11.22 Cr; the latest was in September 2025. Its 10 peer companies in the Healthcare industry (Multi Specialty Hospitals) are compared by revenue, 5 larger and 5 smaller; the largest is Paras Healthcare Limited with revenue of ₹1,314.21 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 13 overdue payments to 4 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shalby.org.

Company Details of Shalby Limited
CIN L85110GJ2004PLC044667
Registration Number 044667
Incorporation Date 30 August 2004
ROC Ahmedabad
Listing Status Listed (BSE: 540797, NSE: SHALBY)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Vikram Indrajit Shah Managing Director Umesh Krishnankutty Menon Director Tej Ramjidass Malhotra Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    shalby.org
  • Social Media
  • Registered Address
    Opp: Karnawati Club Sarkhej Gandhinagar Highway Nr.Prahladnagar Gardern, Ahmedabad, Gujarat, India – 380015
  • Industry
    Healthcare, Hospitals
Comprehensive company report
Shalby Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Shalby Limited report

Financials, compliance, directors, charges, ownership and filings for Shalby Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Shalby Limited

The main business activity of Shalby is hospital and medical care. In detail, this covers hospital activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHospital and Medical CareQ1Hospital activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Shalby Limited FY 2025-26 filings available

Shalby Limited reported revenue of ₹1,141.43 Cr (up 5% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,141 Cr
+5.0% YoY
EBITDA
₹145 Cr
+7.7% YoY
Profit After Tax
₹24.48 Cr
+305.9% YoY
Net Worth
₹1,005 Cr
+1.3% YoY
Total Assets
₹1,615 Cr
+8.7% YoY
Total Debt
₹595 Cr
+24.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,1411,087934805699431487
Revenue growth+5.0%+16.4%+16.0%+15.2%+62.2%-11.5%-
EBITDA14513517913811787.3382.77
EBITDA margin+12.7%+12.4%+19.1%+17.2%+16.8%+20.3%+17.0%
Profit before tax60.5455.7312810279.1655.0556.71
Net profit24.48(11.89)79.2666.5256.0343.1927.15
Net profit margin+2.1%-1.1%+8.5%+8.3%+8.0%+10.0%+5.6%
EPS (₹)3.480.587.836.315.013.932.55
Balance sheet
Total assets1,6151,4861,4001,1221,058901879
Net worth1,0059921,000928876835799
Total debt59547637818015544.0362.21
Cash & bank21.9434.8627.2312.2911183.5728.73
Net working capital482409299256321182136
Cash flow
Cash from operations(0.01)(4.34)19.6067.7818.9279.1555.37
Cash from investing(97.28)(35.64)146(61.08)(60.28)(51.27)(30.67)
Cash from financing84.4147.58(151)(50.00)90.46(29.86)(21.50)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue331287272285296265276268
Revenue growth (YoY)+11.7%+8.5%-1.3%+6.7%+6.3%---
Other income7.418.087.234.487.015.325.427.16
EBITDA41.5929.3530.2641.6141.5420.8433.9032.65
EBITDA margin+12.6%+10.2%+11.1%+14.6%+14.0%+7.9%+12.3%+12.2%
Depreciation18.7418.4917.6117.3716.5216.2316.3216.84
Interest10.579.3410.649.659.3710.6710.669.26
Profit before tax19.699.609.2419.0722.66(0.74)12.3413.71
Tax9.20(8.85)7.9511.8014.9711.4515.3411.34
Net profit10.4918.451.297.277.69(12.19)(3.00)2.37
EPS (₹)0.981.720.120.680.71(1.13)(0.28)0.22
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue899869830708647419484
Revenue growth+3.4%+4.7%+17.2%+9.5%+54.5%-13.5%-
EBITDA14615717914312787.0382.54
EBITDA margin+16.2%+18.1%+21.6%+20.2%+19.6%+20.8%+17.1%
Profit before tax11613615812199.9255.4857.01
Net profit10872.5698.7779.6171.9543.3427.53
Net profit margin+12.0%+8.4%+11.9%+11.2%+11.1%+10.4%+5.7%
EPS (₹)10.507.809.677.536.463.972.59
Balance sheet
Total assets1,3921,2561,1961,016970915894
Net worth1,2471,1341,062970907850814
Total debt13111012134.0841.3144.0362.21
Cash & bank13.3921.669.233.3210482.9728.71
Net working capital17812910582.03250183139
Cash flow
Cash from operations91.1914914016510177.2457.09
Cash from investing(109)(101)(206)(172)(40.32)(51.83)(32.28)
Cash from financing9.16(35.80)72.14(38.21)(17.25)(27.82)(21.50)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue254225214224237207221212
Revenue growth (YoY)+7.2%+8.6%-3.2%+5.5%+1.7%---
Other income5.285.597.515.815.527.196.285.32
Total expenses211194186185190176178177
EBITDA42.4930.7627.9138.9746.8430.7742.5335.43
EBITDA margin+16.7%+13.7%+13.1%+17.4%+19.8%+14.9%+19.3%+16.7%
Depreciation10.8010.5310.009.949.689.639.949.78
Interest3.082.363.554.282.582.663.092.70
Profit before tax33.8923.4621.8730.5640.1025.6735.7828.27
Tax8.82(30.21)8.0910.8114.4110.7214.9110.95

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue331287272285296265276268
Revenue growth (YoY)+11.7%+8.5%-1.3%+6.7%+6.3%---
Other income7.418.087.234.487.015.325.427.16
EBITDA41.5929.3530.2641.6141.5420.8433.9032.65
EBITDA margin+12.6%+10.2%+11.1%+14.6%+14.0%+7.9%+12.3%+12.2%
Depreciation18.7418.4917.6117.3716.5216.2316.3216.84
Interest10.579.3410.649.659.3710.6710.669.26
Profit before tax19.699.609.2419.0722.66(0.74)12.3413.71
Tax9.20(8.85)7.9511.8014.9711.4515.3411.34
Net profit10.4918.451.297.277.69(12.19)(3.00)2.37
EPS (₹)0.981.720.120.680.71(1.13)(0.28)0.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,1411,087934805699431487
Revenue growth+5.0%+16.4%+16.0%+15.2%+62.2%-11.5%-
Other income26.7927.6019.4322.5212.429.0617.37
Total expenses996952755667582344404
Employee cost18818515514411856.9665.50
EBITDA14513517913811787.3382.77
EBITDA margin+12.7%+12.4%+19.1%+17.2%+16.8%+20.3%+17.0%
Depreciation69.9965.7652.2448.0942.8736.8036.02
Interest41.3340.8417.6210.567.534.547.41
Profit before tax60.5455.7312810279.1655.0556.71
Tax25.8753.8144.7034.3725.1712.6929.14
Net profit24.48(11.89)79.2666.5256.0343.1927.15
Net profit margin+2.1%-1.1%+8.5%+8.3%+8.0%+10.0%+5.6%
EPS (₹)3.480.587.836.315.013.932.55
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital108107107107108108108
Reserves & surplus898885893820768727691
Shareholders' funds (net worth)1,0059921,000928876835799
Minority interest0.463.147.41(0.07)(0.14)0.020.05
Secured loans54042731314215544.0348.67
Unsecured loans54.9749.2164.7238.830.000.0013.54
Total debt59547637818015544.0362.21
Total liabilities1,6151,4861,4001,1221,058901879
Assets
Gross block1,4821,3291,285910860804782
Net block1,046955966685675660672
Capital work in progress18.8121.9715.3910.555.777.526.39
Investments62.2694.6380.6414624.7015.6327.99
Inventories38532423718512123.0515.22
Sundry debtors22817514510610194.6994.86
Cash & bank balances21.9434.8627.2312.2911183.5728.73
Loans & advances30.3334.0564.5667.4793.6054.3567.04
Total current assets666569473372426256206
Total current liabilities18416017411510573.2169.72
Net working capital482409299256321182136
Total assets1,6151,4861,4001,1221,058901879
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash34.7927.1812.2455.556.488.465.26
Net cash from operating activities(0.01)(4.34)19.6067.7818.9279.1555.37
Net cash from investing activities(97.28)(35.64)146(61.08)(60.28)(51.27)(30.67)
Net cash from financing activities84.4147.58(151)(50.00)90.46(29.86)(21.50)
Net change in cash(12.88)7.6114.94(43.31)49.10(1.98)3.21
Closing cash21.9434.8627.2312.2911183.5728.73
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+5.0%+16.4%+16.0%+15.2%+62.2%-11.5%-
EBITDA growth+7.7%-24.6%+29.3%+18.0%+34.1%+5.5%-
PBT growth+8.6%-56.5%+25.6%+28.9%+43.8%-2.9%+12.5%
Net income growth+305.9%-115.0%+19.2%+18.7%+29.7%+59.1%-
Revenue CAGR (3Y)+12.4%+15.9%+29.4%+18.3%+14.8%+4.5%+14.6%
EBITDA CAGR (3Y)+1.6%+4.8%+26.9%+18.6%+12.0%+3.4%+5.0%
Profitability & leverage
Net income margin+3.0%+0.2%+8.9%+8.4%+7.7%+9.8%+5.7%
Return on capital employed+6.1%+6.1%+11.6%+10.3%+8.9%+6.7%+7.4%
Return on net worth+2.2%-1.6%+8.7%+7.5%+6.3%+5.2%+3.5%
Debt / equity0.540.430.290.190.120.070.08
Long-term debt / equity0.190.200.170.100.070.050.07
Interest cover55.0559.2113.9411.7210.148.9815.85
Efficiency & per share
Fixed asset turnover0.810.830.850.910.840.540.63
Inventory turnover3.223.874.425.259.6922.5234.74
Debtors turnover5.666.807.447.767.144.555.53
EPS (₹)3.480.587.836.315.013.932.55
Dividend per share (₹)0.000.001.201.201.001.000.50
Book value per share (₹)93.4992.3193.1386.4581.1377.2874.00
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue254225214224237207221212
Revenue growth (YoY)+7.2%+8.6%-3.2%+5.5%+1.7%---
Other income5.285.597.515.815.527.196.285.32
Total expenses211194186185190176178177
EBITDA42.4930.7627.9138.9746.8430.7742.5335.43
EBITDA margin+16.7%+13.7%+13.1%+17.4%+19.8%+14.9%+19.3%+16.7%
Depreciation10.8010.5310.009.949.689.639.949.78
Interest3.082.363.554.282.582.663.092.70
Profit before tax33.8923.4621.8730.5640.1025.6735.7828.27
Tax8.82(30.21)8.0910.8114.4110.7214.9110.95
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue899869830708647419484
Revenue growth+3.4%+4.7%+17.2%+9.5%+54.5%-13.5%-
Other income24.8630.2720.7019.5713.009.6217.74
Total expenses753712651565520332401
Employee cost11210998.0586.7678.3255.7465.25
EBITDA14615717914312787.0382.54
EBITDA margin+16.2%+18.1%+21.6%+20.2%+19.6%+20.8%+17.1%
Depreciation40.1538.8937.0837.0635.5036.6735.86
Interest14.4812.664.324.444.404.507.41
Profit before tax11613615812199.9255.4857.01
Tax3.0951.9554.4740.5530.1112.6129.06
Net profit10872.5698.7779.6171.9543.3427.53
Net profit margin+12.0%+8.4%+11.9%+11.2%+11.1%+10.4%+5.7%
EPS (₹)10.507.809.677.536.463.972.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital108107107107108108108
Reserves & surplus1,1391,027955863799742706
Shareholders' funds (net worth)1,2471,1341,062970907850814
Secured loans12010311425.5041.3144.0348.67
Unsecured loans11.726.677.468.580.000.0013.54
Total debt13111012134.0841.3144.0362.21
Total liabilities1,3921,2561,1961,016970915894
Assets
Gross block950868851817806802779
Net block621579599603628658670
Capital work in progress0.268.045.2410.055.747.526.39
Investments62359951131362.0932.1042.75
Inventories24.6620.2519.2019.6219.8319.9414.76
Sundry debtors18013211889.6494.3093.0091.49
Cash & bank balances13.3921.669.233.3210482.9728.71
Loans & advances88.1758.6156.7664.1711360.9873.59
Total current assets306232203177332257209
Total current liabilities12810397.7294.7281.3373.8369.71
Net working capital17812910582.03250183139
Total assets1,3921,2561,1961,016970915894
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash21.609.203.2949.396.028.445.12
Net cash from operating activities91.1914914016510177.2457.09
Net cash from investing activities(109)(101)(206)(172)(40.32)(51.83)(32.28)
Net cash from financing activities9.16(35.80)72.14(38.21)(17.25)(27.82)(21.50)
Net change in cash(8.25)12.405.91(46.09)43.36(2.41)3.31
Closing cash13.3921.669.233.3210482.9728.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.4%+4.7%+17.2%+9.5%+54.5%-13.5%-
EBITDA growth-7.2%-12.3%+24.9%+13.0%+45.7%+5.4%-
PBT growth-14.5%-14.3%+30.4%+21.5%+80.1%-2.7%+12.4%
Net income growth+49.0%-26.5%+24.1%+10.7%+66.0%+57.4%-
Revenue CAGR (3Y)+8.3%+10.3%+25.6%+13.5%+11.8%+3.3%+14.5%
EBITDA CAGR (3Y)+0.6%+7.4%+27.2%+20.2%+14.9%+2.9%+4.4%
Profitability & leverage
Net income margin+12.6%+9.6%+12.5%+11.4%+10.8%+10.2%+5.8%
Return on capital employed+9.9%+12.1%+14.7%+12.7%+11.1%+6.6%+7.3%
Return on net worth+9.5%+7.6%+10.2%+8.6%+8.0%+5.2%+3.5%
Debt / equity0.100.110.080.040.050.060.08
Long-term debt / equity0.080.090.060.030.030.050.07
Interest cover13.7110.723.044.184.828.9415.87
Efficiency & per share
Fixed asset turnover0.991.011.000.870.800.530.63
Inventory turnover40.0244.0542.7435.8932.5324.1335.32
Debtors turnover5.776.978.007.706.914.545.60
EPS (₹)10.507.809.677.536.463.972.59
Dividend per share (₹)0.000.001.201.201.001.000.50
Book value per share (₹)115.97105.5098.8990.4283.9578.6675.34
Want more history and ratios?
You're viewing the latest exchange-filed financials for Shalby Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Peer Comparison of Shalby Limited

Shalby Limited is compared with the companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Paras Healthcare Limited₹1,314.21 Cr (FY 2025)••••••••14.0%••••Gurugram, Haryana, India
Jupiter Life Line Hospitals Limited₹1,290.22 Cr (FY 2025)••••••••18.0%••••Mumbai, Maharashtra, India
Kims Health Care Management Limited₹1,281.97 Cr (FY 2025)••••••••15.0%••••Thiruvananthapuram, Kerala, India
Manipal Hospitals (East) India Private Limited₹1,143.99 Cr (FY 2025)••••••••6.0%••••Kolkata, West Bengal, India
Shalby Limited this company₹1,141.43 Cr (FY 2026)••••••••5.0%••••Ahmedabad, Gujarat, India
Malabar Institute of Medical Sciences Ltd₹1,127.68 Cr (FY 2025)••••••••11.0%••••Kozhikode, Kerala, India
Gleneagles Healthcare India Private Limited₹1,064.66 Cr (FY 2025)••••••••5.0%••••Chennai, Tamil Nadu, India
Sahyadri Hospitals Private Limited₹1,046.76 Cr (FY 2025)••••••••24.0%••••Pune, Maharashtra, India
Crosslay Remedies Limited₹1,001.64 Cr (FY 2025)••••••••21.0%••••Gurgaon, Haryana, India
Artemis Medicare Services Limited Listed₹969.9 Cr (FY 2025)••••••••9.0%••••New Delhi, Delhi, India
Yatharth Hospital & Trauma Care Services Limited₹896.66 Cr (FY 2025)••••••••31.0%••••Centre, Delhi, India

Peers are the five companies nearest above and the five nearest below Shalby by revenue in the Healthcare industry (Multi Specialty Hospitals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Shalby Limited

Shalby Limited is audited by T R Chadha & Co LLP for the financial year 2021.

NameStatusAppointment DateCessation Date
T R Chadha & Co LLPLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Shalby Limited

Shalby has 6 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vikram Indrajit Shah
Also directs: Shalby Medtech Limited, Shalby Advanced Technologies India Private Limited, Uranus Medical Devices Limited and 3 more
Managing Director30 Aug 200422 Years 1 MonthsCurrent
Umesh Krishnankutty Menon
Also directs: Mundial Netz LLP, Arunaya Organics Limited, Dharmaj Crop Guard Limited and 3 more
Director20 Dec 20169 Years 9 MonthsCurrent
Tej Ramjidass Malhotra
Also directs: Macro Polymers Pvt Ltd, Meghmani Industries Limited
Director23 Feb 20179 Years 7 MonthsCurrent
Ashok Bhatia
Also directs: Onnext Advisors LLP, Zim Laboratories Limited.
Director23 Oct 20178 Years 11 MonthsCurrent
Sujana Manan Shah
Also directs: Shalby Medtech Limited, PK Healthcare Private Limited
Director07 May 20188 Years 5 MonthsCurrent
Shyamal Shivkumar Joshi
Also directs: Shalby Medtech Limited, GVK Airport Holdings Limited, GVK Airport Developers Limited and 3 more
Director30 Sep 201511 Years 0 MonthsCurrent
View all directors

Shareholding Pattern of Shalby Limited

Shareholding for the quarter ended Sep 2026: promoters hold 74.30%, foreign institutional investors hold 4.50%, domestic institutional investors hold 0.30% and retail and other public shareholders hold 20.90%.

Promoters: 74.30%DII (Domestic Institutional): 0.30%FII (Foreign Institutional): 4.50%Retail & Others: 20.90%
Sep 2026
QUARTER
74.30% Promoters
0.30% DII (Domestic Institutional)
4.50% FII (Foreign Institutional)
20.90% Retail & Others
Promoter holding - history
Now 74.30% · Sep 2026High 74.30% · Dec 2025Low 74.30% · Dec 2025
73%73.8%74.5%75.3%76%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 74.30%Mar 2026: 74.30%Jun 2026: 74.30%Sep 2026: 74.30%74.30%74.30%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters74.30%74.30%74.30%74.30%
Public25.70%25.70%25.70%25.70%

Charges & Borrowings of Shalby Limited

Open charges
₹582.62 Cr
Satisfied charges
₹473.03 Cr
Breakdown by lending institutions
Others₹369.88 Cr
Citi Bank N.A.₹111.85 Cr
Hdfc Bank Limited₹100.89 Cr
Latest charge details
DateLenderAmountStatus
17 Feb 2026Others₹199.88 CrOpen
29 Mar 2025Citi Bank N.A.₹111.85 CrOpen
06 Aug 2024Hdfc Bank Limited₹60 CrOpen
07 Feb 2023Others₹170 CrOpen
14 Oct 2021Hdfc Bank Limited₹88.72 LakhOpen

Total charge records: 46 View all charges

Deals & Funding of Shalby Limited

Shalby Limited has 30 deals on record (13 secondary share transfers, 9 market trades, 7 funding rounds), with disclosed funding of ₹11.22 Cr; the latest was in September 2025.

Total deals
30
Secondary share transfers
13
Market trades
9
Funding rounds
7
IPO
1
Disclosed funding
₹11.22 Cr

Deals on record (5 of 30)

WhenDealAmountParties
Sep 2025Market trade₹36.09 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Sep 2025Market trade₹24.97 CrBuyer: NK Securities Research Private Limited , Musigma Securities
Seller: NK Securities Research Private Limited , Musigma Securities
Jul 2021Market trade₹10.42 CrBuyer: Olga Trading Private Limited
Seller: Olga Trading Private Limited
Aug 2019Secondary share transferUndisclosedBuyer: Dynavision Ventures LLP , Others -Shalby Limited
Seller: Kotak Funds - India Midcap Fund, IIFL India Growth Fund, Kunvarji Fincorp Private Limited
Mar 2017Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 4 individuals
Premium access

Full deal history

All 30 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Shalby Limited

Shalby Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 13 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (4 of 4)

SupplierAmount dueDue sinceReported on
an individual supplier••••••••••••
an individual supplier••••••••••••
JMD Pharma Indore••••••••••••
an individual supplier••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Shalby Limited

Shalby operates multiple associated brands including Shalby Academy, Shalby, and Shalby Hospitals. Each brand links to its own profile.

BrandDescriptionWebsite
Shalby Academy
Offers medical education, training programs, and healthcare up-skilling for professionals.shalbyacademy.com
Shalby
Delivers comprehensive home nursing care services.shalbyhomecare.org
Shalby Hospitals
Multi-specialty hospital services are delivered through a chain in India.shalby.org

Employees and EPFO Compliance at Shalby Limited

Shalby Limited has a workforce of 2,529 employees as of Apr 07, 2024.

Employee count
2,529
Active EPFO establishments
2
Employee growth
8.77%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Shalby Limited

Shalby has 6 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

6
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Mars Medical Devices LimitedU33100GJ2020PLC113358-
Slaney Healthcare Private LimitedU33125GJ2008PTC052648-
Shalby International LimitedU85100GJ2012PLC071824-
Shalby Hospitals Mumbai Private LimitedU85100GJ2020PTC118765-
Vrundavan Shalby Hospitals LimitedU85110GA1995PLC001851-
Yogeshwar Healthcare LimitedU85110GJ1997PLC032486-

Showing major subsidiaries. Total: 6.

Name History of Shalby Limited

Shalby has undergone 4 name changes throughout its history. The current legal name is Shalby Limited.

Company NameStatus
Shalby LimitedCurrent
Shalby Hospital Public LimitedPrevious
Shalby Hospitals LimitedPrevious
Shalby Hospital LimitedPrevious
Shalby Hospital Private LimitedPrevious

CIN History of Shalby Limited

Shalby has one previous CIN (Corporate Identification Number): U85110GJ2004PLC044667. The current CIN is L85110GJ2004PLC044667, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85110GJ2004PLC044667Current
U85110GJ2004PLC044667Previous

News related to Shalby Limited

Recent Activity on Shalby Limited

Shalby Limited has 38 board changes on record since 2004: 23 appointments and 15 cessations. The latest: Amit Pathak ceased to be CFO on 24 Oct 2025.

Charges
A charge with Others of Rs. 199.88 Cr registered on 17 Feb 2026 with Charge ID 101251177 was modified on 06 Mar 2026.
Charges
A charge registered on 17 Dec 2021 via Charge ID 100514139 with Sbicap Trustee Company Limited was fully satisfied on 23 Feb 2026.
Charges
A charge with Others amounted to Rs. 199.88 Cr with Charge ID 101251177 was registered on 17 Feb 2026.
Charges
A charge registered on 05 Jun 2017 via Charge ID 100107113 with Others was fully satisfied on 06 Feb 2026.
Charges
A charge registered on 29 Aug 2024 via Charge ID 100975232 with Others was fully satisfied on 12 Nov 2025.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 168.53 Cr registered on 17 Dec 2021 with Charge ID 100514139 was modified on 28 Oct 2025.
Ceased
Amit Pathak ceased to be CFO.
AGM
Shalby Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge registered on 18 Jun 2022 via Charge ID 100590732 with Hdfc Bank Limited was fully satisfied on 20 Sep 2025.
Charges
A charge registered on 19 Jan 2016 via Charge ID 10617364 with Sbicap Trustee Company Limited was fully satisfied on 23 Apr 2025.
Filing
Shalby Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Citi Bank N.A. amounted to Rs. 111.85 Cr with Charge ID 101076023 was registered on 29 Mar 2025.

126 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Shalby Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Shalby Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Shalby Limited

Shalby has 4 GST registrations: 4 active.

Total GSTINs
4
Active
4
GSTINStateStatusRegistered on
03AAICS5593B1ZGPunjabActive01 Jul 2017
08AAICS5593B1Z6RajasthanActive01 Jul 2017
23AAICS5593B1ZEMadhya PradeshActive01 Jul 2017
27AAICS5593B1Z6MaharashtraActive11 Jan 2018
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Shalby Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shalby Limited

Shalby is an active public limited company based in Ahmedabad, Gujarat, India. The company works in hospitals, within the healthcare industry. It was incorporated on 30 August 2004 (22+ years old) and is registered under CIN L85110GJ2004PLC044667. Listed on BSE: 540797 and NSE: SHALBY.

Shalby reported revenue of ₹1,141.43 Cr for FY 2025-26 (up 5% YoY) based on consolidated financials.

Shalby has 6 current directors:

The GSTIN of Shalby is 03AAICS5593B1ZG, registered in Punjab. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 08AAICS5593B1Z6 (Rajasthan), 23AAICS5593B1ZE (Madhya Pradesh), 27AAICS5593B1Z6 (Maharashtra).

The CIN (Corporate Identification Number) of Shalby is L85110GJ2004PLC044667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Shalby is listed on both BSE (code: 540797) and NSE (symbol: SHALBY).

Shalby has 84 court cases on record: 53 filed by the company and 22 filed against it. 16 are pending. Most are in the district courts.

Shalby was incorporated on 30 August 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Shalby has 30 deals on record (13 secondary share transfers, 9 market trades, 7 funding rounds), with disclosed funding of ₹11.22 Cr; the latest was in September 2025.

The peers of Shalby by revenue are Paras Healthcare Limited, Jupiter Life Line Hospitals Limited, Kims Health Care Management Limited, Manipal Hospitals (East) India Private Limited, Malabar Institute of Medical Sciences Ltd and 5 more, all in the Healthcare industry (Multi Specialty Hospitals).

Amit Pathak ceased to be CFO on 24 Oct 2025. Sushobhan Dasgupta ceased to be Director on 31 Jan 2024. Amit Pathak was appointed as CFO on 19 May 2023. Shalby has 38 board changes on record in total.

Shalby has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 13 overdue payments to 4 micro and small suppliers. The latest return was filed on 30 Apr 2024.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available